AI BIO Snapshot Meeting

⚠️ IMPORTANT UPDATES

Due to the government shutdown, we just received notifications from multiple speakers that we must reschedule or cancel this event.

We apologize for the inconvenience and will keep you updated on the next steps.

We hope we can stay connected! Thank you very much for your support!

This meeting series aims to bring together scientists, investors, and founders to strengthen collaboration and sustain progress at the intersection of AI and biomedicine, recognizing the challenges of securing grants in the current research funding landscape.

The topics of this meeting include some progress made since the release of GPT-3. Additional scientists and founders will be invited to future meetings in this series.

View Events

AI BIO Snapshot Meeting

Time: 11:00 AM EST, Oct 4, 2025

Location: Online

Registration Fee: Free

Register Now
Registration QR Code Scan to Register Closes at 9:00 PM EST on 10/3/2025 A Zoom link will be sent around 8:00 PM EST on 10/2
Submit Pitch
BP Submission QR Code Scan to Submit Closes at 11:59 PM EST on 10/1/2025 Please kindly provide only generic information Avoid including any proprietary details

Meeting Schedule

This session covers AI research across 6 distinct fields: genomics, transcriptomics, protein engineering, small-molecule drug design, materials science and drug delivery systems, and foundation models.

11:00 - 11:20
NSF Representative
NSF & Getting Started

NSF New England I-Corps Hub Perspective

This session for students and post-docs introduces the new NSF New England I-Corp Hub and NSF programs and funding pathways to advance your research and ideas towards commercialization, entrepreneurship, and broader impact.

11:25 - 11:40
Dr. Vijay Pande
Dr. Vijay Pande

Co-Founder of VZVC, Founder and former Managing Partner of the a16z Bio + Health Fund, Adjunct Professor at Stanford University, Co-founded Globavir Biosciences, On the boards of more than 14 companies including Slingshot AI, Apeel Sciences, Bayesian Health, Devoted Health, Nautilus Biotechnology and Scribe Therapeutics.

AI Meets Biomedicine: Innovation and Investment

11:45 - 12:00 Keynote
Prof. David Baker
Prof. David Baker

Director of the Institute for Protein Design at University of Washington, Co-founder of a number of companies including Xaira Therapeutics, Prospect Genomics, Icosavax, PvP Biologics, Pregenen and Neoleukin Therapeutics.

Nobel Prize in Chemistry 2024

Computational protein design

12:05 - 12:25
Dr. Žiga Avsec
Dr. Žiga Avsec

Senior Staff Research Scientist at Google DeepMind

AlphaGenome (bioRxiv)

12:30 - 12:50
Dr. Yusuf Roohani
Dr. Yusuf Roohani

Machine Learning Group Lead at Arc Institute, Visiting Scholar at Stanford

Virtual Cell Challenge (Cell), In silico prediction of gene expression using STATE model (bioRxiv)

12:55 - 1:15
Prof. Manolis Kellis
Prof. Manolis Kellis

Head of Computational Biology Group at MIT

Beyond chatbots: unleashing human creativity through visual AI, multimodal deep representation learning, and agentic workflows in chemistry, biological structures, and functions

1:20 - 1:40
Dr. Kevin Yang
Dr. Kevin Yang

Principal Researcher at Microsoft, Trainee of Dr. Frances Arnold

AI-aided Protein Engineering. Nature Methods Papers 1 and 2

1:45 - 2:05
Dr. Jacob Witten
Dr. Jacob Witten

Postdoc Fellow with Dr. Robert Langer and Dr. Daniel Anderson at MIT, Received Assistant Professor Offers

Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nature Biotechnology

2:10 - 2:30
Dr. Pat Walters
Dr. Pat Walters

Chief Scientist at OpenADMET, with prior leadership roles at Relay Therapeutics (NASDAQ: RLAY) and Vertex Pharmaceuticals (NASDAQ: VRTX)

How AI is impacting drug discovery and current challenges in the field

AI BIO Startup Connect

This session connects startups with talent. Open to everyone. Free.

2:35 - 2:37
Lub-Dub-Lab
Lub Dub Lab

A startup from MIT Sloan is seeking technical experts and talent.

AI BIO Startup Spotlight & Pitch Session

All startups are in early stages (pre-B), with some still in stealth mode. To protect their information, this session is open only to invited investors. Free.

2:50 - 3:00
Dr. Eli Pollock
Ontologic, Dr. Eli Pollock (MIT)

Startup presentation and Q&A session.

3:00 - 3:10
GT-BIO
GT Biosciences, Dr. Tay Shin and Dr. Chi Zhang (MIT)

Startup presentation and Q&A session.

3:10 - 3:20
Dr.Bo Li
QuanMol Tech, Dr. Bo Li (Berkeley)

Startup presentation and Q&A session.

Investors
Patricia Geli
Dr. Patricia Geli

Managing Partner & COO of C10 Labs

Shahid-Azim
Shahid Azim

Managing Partner & CEO of C10 Labs

Dr.Dionysios Panagiotopoulos
Dr. Dionysios Panagiotopoulos

Partner at LDV Partners

Lu Zhang
Lu Zhang

Founder and Managing Partner, Fusion Fund

Sherwin Kuo
Dr. Sherwin Kuo

Investor, Fusion Fund

Rocky Yu
Rocky Yu

Founder and CEO of AGI House